Psoriasis is driven by the innate and adaptive immune systems, partly characterized by the chronic activation of T-helper cells (Th17) and secretion of proinflammatory cytokines such as interleukin 17 (IL-17) and tumor necrosis factor-α (TNF-α) in response to IL-23 (5). Here, IL17A is linked to psoriasis.